HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)

PHASE2RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 21, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
NASH
Interventions
DRUG

HuHuangLianzonggan capsule

HuHuangLianzonggan capsule, 4 pills(120 mg per pill), take orally after meals, 2 times a day for 12weeks

DRUG

HuHuangLianzonggan capsule placebo

HuHuangLianzonggan capsule placebo, 4 pills(120 mg per pill), take orally after meals, 2 times a day for 12weeks

Trial Locations (20)

Unknown

NOT_YET_RECRUITING

Anhui Provincial Hospital, Hefei

NOT_YET_RECRUITING

The Second Hospital of Anhui Medical University, Hefei

RECRUITING

Peking University Third Hospital, Beijing

NOT_YET_RECRUITING

The first affiliated hospital of Fujian medical university, Fuzhou

NOT_YET_RECRUITING

Nanfang Hospital, Southern Medical University, Guangzhou

RECRUITING

The Third People's Hospital of Shenzhen, Shenzhen

RECRUITING

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang

RECRUITING

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

RECRUITING

The First People's Hospital of Lianyungang, Lianyungang

NOT_YET_RECRUITING

The Affiliated Hospital of Nanjing University medical school,Nanjing Drum Tower Hospital, Nanjing

RECRUITING

The Second Hospital of Nanjing, Nanjing

RECRUITING

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

NOT_YET_RECRUITING

General Hospital of Ningxia Medical University, Yinchuan

RECRUITING

Sichuan Provincial People's Hospital, Chengdu

RECRUITING

Tianjin Second People's Hospital, Tianjin

RECRUITING

The Affiliated Hospital of Hangzhou Normal University, Hangzhou

RECRUITING

Ningbo Huamei Hospital, University of Chinese Academy of Sciences, Ningbo

RECRUITING

Ningbo Medical Center Lihuili Hospital, Ningbo

RECRUITING

Taizhou Municipal Hospital, Taizhou

RECRUITING

Rui'an People's Hospital, Wenzhou

All Listed Sponsors
lead

Tasly Pharmaceutical Group Co., Ltd

INDUSTRY